Pharmacists' perception about design and content of medicine labels on prescription services in community pharmacies
DOI:
https://doi.org/10.46542/pe.2023.234.300303Keywords:
Community pharmacist, Medication error, Perception, Prescription medicine labelingAbstract
Background: Differences in perception among pharmacists and the absence of standards or regulations for labelling prescribed medicines in Indonesia make the labels patients receive have different designs and contents. Incomplete information and insufficient medicine label design can lead to medication errors.
Objective: This study aimed to determine the pharmacists’ perception of the design and content of prescribed medicine labels.
Method: This study was conducted by survey using an online questionnaire developed based on the "FIP Guidelines for The Labels of Prescribed Medicines" and Regulation of the Minister of Health of the Republic of Indonesia number. 73 the year 2016 concerning Pharmaceutical Service Standards in Pharmacies. Questionnaires were distributed through personal chat and social media groups of community pharmacists.
Result: A total of 925 pharmacists from 32 provinces of Indonesia participated in this study. Respondents considered the most important information on the label of prescribed drugs namely instructions for drug use (84.6%), patient name (81.6%), pharmacy name (76.1%), special instructions (71.5%), and pharmacist name (63.9%). For the label’s design, most respondents preferred printed and handwritten labels (61.2%).
Conclusion: It can be concluded that different pharmacists' perceptions affect the labelling of prescribed medicines. There is a need for regulations or standards of labelling prescribed medicines.
References
Adejare, A. (2016). Remington the scinece and practice of Pharmacy 23rd Edition (Vol. 4, Issue 1).
Aronson, J. K. (2009). Medication errors: Definitions and classification. British Journal of Clinical Pharmacology, 67(6), 599–604.https://doi.org/10.1111/j.1365-2125.2009.03415.x
Badan POM RI. (2015). Provision of drug information to improve patient adherence. https://pionas.pom.go.id/ioni/lampiran-6-petunjuk-praktis-penggunaan-obat-yang-benar/pemberian-informasi-obat-untuk
Berman, A. (2004). Reducing medication errors through naming, labeling, and packaging. Journal of Medical Systems, 28(1), 9–29. https://doi.org/10.1023/b:joms.0000021518.60670.10
Goverment of Canada. (2019). Good label and package practices guide for prescription drugs. Health Canada. https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/good-label-package-practices-guide-prescription-drugs-profile/guidance-document.html#a34
International Pharmaceutical Federation. (2001). FIP guidelines for the labels of prescribed medicines. FIP Council in Singapore, September 2001, 1–4.
Kemenkes RI. (2016). Regulation of the Minister of Health Number 73 of 2016 concerning Pharmaceutical Service Standards in Pharmacies. Ministry of Health of the Republic of Indonesia PA. Accessed on https://www.who.int/indonesia/news/publications
Leat, S. J., Ahrens, K., Krishnamoorthy, A., Gold, D., & Rojas-Fernandez, C. H. (2014). The legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labels. Canadian Pharmacists Journal, 147(3), 179–187. https://doi.org/10.1177/1715163514530094
National Coordinating Council for Medication Error Reporting and Prevention. (2022). No Title. https://www.nccmerp.org/about-medication-errors
Samsiah, A., Othman, N., Jamshed, S., Hassali, M. A., & Wan-Mohaina, W. M. (2016). Medication errors reported to the National Medication Error Reporting System in Malaysia: a 4-year retrospective review (2009 to 2012). European Journal of Clinical Pharmacology, 72(12), 1515–1524. https://doi.org/10.1007/s00228-016-2126-x
Shrank, W., Avorn, J., Rolon, C., & Shekelle, P. (2007). Effect of content and format of prescription drug labels on readability, understanding, and medication use: A systematic review. Annals of Pharmacotherapy, 41(5), 783–801. https://doi.org/10.1345/aph.1H582
Shrank, W. H., Parker, R., Davis, T., Pandit, A. U., Knox, J. A. P., Moraras, P., Rademaker, A., & Wolf, M. S. (2010). Rationale and design of a randomized trial to evaluate an evidence-based prescription drug label on actual medication use. Contemporary Clinical Trials, 31(6), 564–571. https://doi.org/10.1016/j.cct.2010.07.004
Wolf, M. S., Davis, T. C., Shrank, W., Rapp, D. N., Bass, P. F., Connor, U. M., Clayman, M., & Parker, R. M. (2007). To err is human: Patient misinterpretations of prescription drug label instructions. Patient Education and Counseling, 67(3 SPEC. ISS.), 293–300. https://doi.org/10.1016/j.pec.2007.03.024
